A comparative longitudinal quality of life study using the Spitzer quality of life index in a randomized multicenter phase III trial (FFCD 9102): chemoradiation followed by surgery compared with chemoradiation alone in locally advanced squamous resectable
Fiche publication
Date publication
mai 2006
Journal
Annals of oncology : official journal of the European Society for Medical Oncology
Auteurs
Membres identifiés du Cancéropôle Est :
Pr BEDENNE Laurent, Pr BOUCHE Olivier, Pr CONROY Thierry
Tous les auteurs :
Bonnetain F, Bouché O, Michel P, Mariette C, Conroy T, Pezet D, Roullet B, Seitz JF, Paillot B, Arveux P, Milan C, Bedenne L
Lien Pubmed
Résumé
The aim of the study was to compare the longitudinal quality of life (QoL) between chemoradiation with or without surgery in patients with locally advanced squamous resectable esophageal cancer included in a randomized multicenter phase III trial (FFCD 9102).
Mots clés
Adenocarcinoma, drug therapy, Antineoplastic Combined Chemotherapy Protocols, therapeutic use, Carcinoma, Squamous Cell, drug therapy, Combined Modality Therapy, Esophageal Neoplasms, drug therapy, Esophagectomy, Female, Follow-Up Studies, Humans, Longitudinal Studies, Male, Middle Aged, Quality of Life, Radiotherapy Dosage, Survival Rate
Référence
Ann. Oncol.. 2006 May;17(5):827-34